Changes in the diameter and valve closure time of leg veins across the menstrual cycle

Journal of Ultrasound in Medicine

Volumn 33, Issue 5, 2014, Pages 803-809

  Asbeutah, Akram M ^a   Al Enezi, Maitha ^a   Al Sharifi, Noura M ^a   Almajran, Abdullah ^a   Cameron, James D ^b   McGrath, Barry P ^c   Asfar, Sami K ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b SOUTHERN HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Duplex ultrasound; Female sex hormones; Leg veins; Menstrual cycle; Varicose veins; Vascular ultrasound

Indexed keywords

HEALTH; HORMONES;

LEG VEINS; MENSTRUAL CYCLE; SEX HORMONES; VARICOSE VEINS; VASCULAR ULTRASOUND;

ULTRASONICS;

DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; LEG; MENSTRUAL CYCLE; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VASCULAR RESISTANCE; VASCULARIZATION; VEIN VALVE; YOUNG ADULT;

FEMALE; HUMANS; LEG; MENSTRUAL CYCLE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR RESISTANCE; VENOUS VALVES; YOUNG ADULT;

EID: 84899494310     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.33.5.803     Document Type: Article

References (30)

1. Abramson JH, Hopp C, Epstein LM. The epidemiology of varicose veins: a survey of western Jerusalem. J Epidemiol Community Health 1981;35:213-217.
2. Sadick NS. Predisposing factors of varicose veins and teangiectatic leg veins. J Dermatol Surg Oncol 1992;18:883-886.
3. Hanrahan LM, Kechejiaan J, Cordts RR, et al. Patterns of venous insufficiency in patients with varicose veins. Arch Surg 1991;126:687-691.
4. Widmer LK, Stahelin HB, Da Silva A. Peripheral Venous Disorders: Prevalence and Socio-Medical Importance-Observations in 4529 Apparently Healthy Persons: Basel III Study. Bern, Switzerland: Hans Huber; 1978:1-10.
5. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham study. Am J Prev Med 1988;4:96-101.
6. Bylebyl JJ. Boyle and Harvey on the valves in the veins. Bull Hist Med 1982;56:351-367.
7. Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534-543.
8. Hoare MC, Nicolaides AN, Miles CR, et al. The role of primary varicose veins in venous ulceration. Surgery 1982;92:450-453.
9. Nicolaides AN, Hussein MK, Szendro G, Christopoulos D, Vasdekis S, Clarke H. The relation of venous ulceration with ambulatory venous pressure measurements. J Vasc Surg 1993;17:414-419.
10. Dindelli M, Parazzini F, Basellini A, Rabaiotti E, Corsi G, Ferrari A. Risk factors for varicose veins before and during pregnancy. Angiology 1993;44:361-367.
11. Franks PJ, Wright DD, McCollum CN. Epidemiology of venous disease: a review. Phlebology 1989;4:143-151.
12. Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 1995;22:622-628.
13. Hairai M, Kenichi N, Nakayama R. Prevalence and risk factors of varicose veins in Japanese women. Angiology 1990;41:228-232.
14. Maffei FH, Magaldi C, Pinho SZ, et al. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986;15:210-217.
15. Arnoldi CC. The aetiology of primary varicose veins. Dan Med Bull 1957;4:102-107.
16. Fanfera FJ, Palmer LH. Pregnancy and varicose veins. Arch Surg 1968;96:33-35.
17. Ciardullo AV, Panico S, Bellati C, et al. High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg 2000;32:544-549.
18. Cohen J. Venous insufficiency and oral contraception [in French]. Rev Fr Gynecol Obstet 1991;86:187-189.
19. Wenner L. Varicosity, hormones and pregnancy [in German]. Vasa 1979;8:258-262.
20. Wood JE. The cardiovascular effects of oral contraceptives. Mod Concepts Cardiovasc Dis 1972;41:37-40.
21. Mashiah A, Berman V, Thole HH, et al. Estrogen and progesterone receptors in normal and varicose saphenous veins. Cardiovasc Surg 1999;7:327-331.
22. Perrot-Applanat M. Estrogen receptors in the cardiovascular system. Steriods 1996;61:212-215.
23. Vin F, Allaert FA, Levardon M. Influence of estrogens and progesterone on the venous system of the lower limbs in women. J Dermatol Surg Oncol 1992;18:888-892.
24. Schmidt JB, Seidl K, Spona J. Hormone interactions in varicose veins: receptor analysis and hormone level [in German]. Vasa 1986;15:224-227.
25. Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995;21:635-645.
26. Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-1252.
27. Raghavendra BN, Horii SC, Hilton S, Subramayam BR, Rosen RJ, Lam S. Deep venous thrombosis: detection by probe compression of veins. J Ultrasound Med 1986;5:89-95.
28. Van Bemmelen PS, Bedford G, Beach K, Strandness DE. Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg 1989;10:425-431.
29. Labropoulos N, Tiongson J, Pryor L, et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003;38:793-798.
30. Pemble LB, Effeney DJ, Thomas BJ. Cross-sectional area changes in leg vein at different stages of the menstrual cycle. J Vasc Technol 1996;20:143-147.